BioXell Initiates Phase II Clinical Trial with BXL-628 in Benign Prostatic Hyperplasia MILAN, Italy, March 27, 2003 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company, today announced that it has initiated recruitment for the Phase II trial of its novel lead compound,...